Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Alleviant ALLAY-HF Study

NCT: NCT05685303 · RECRUITING

NCT IDNCT05685303
StatusRECRUITING
Start Date2023-01-10
Completion2032-12-01
SponsorAlleviant Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑